IDH1 and malignant conjunctival melanoma: In conclusion, our study demonstrates a significant loss of 5-hmC in conjunctival melanoma compared to nevi, a loss not only linked to a decrease in the expression of TET2 but also possibly to alterations in its function as suggested by the presence of IDH1 mutations identified in 29% of conjunctival melanomas.